Security key
45719W205
Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (IKT)
CUSIP: 45719W205
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 140,000,283
- Total 13F shares
- 235,004
- Share change
- -194,658
- Total reported value
- $298,925
- Price per share
- $1.27
- Number of holders
- 11
- Value change
- -$271,105
- Number of buys
- 5
- Number of sells
- 7
Report period
Q4 2023
Institutions
11
Top holders
10
IKT full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Inhibikase Therapeutics, Inc. SEC filings
Inhibikase Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45719W205
Recent filing periods:
Top shareholders of IKT - Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.13%
|
186,046
|
$258,604 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.06%
|
87,447
|
$121,551 | — | 30 Sep 2023 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.04%
|
59,375
|
$82,531 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
28,692
|
$40,488 | — | 30 Sep 2023 | |
| Redmond Asset Management, LLC |
13F
|
Company |
0.01%
|
20,977
|
$29,158 | — | 30 Sep 2023 | |
| EDGEWOOD MANAGEMENT LLC |
13F
|
Company |
0.01%
|
16,666
|
$23,166 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.01%
|
16,122
|
$22,000 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
10,084
|
$14,218 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,200
|
$3,058 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,667
|
$2,317 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
232
|
$322 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
149
|
$207 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
5
|
$7 | — | 30 Sep 2023 | |
| Joseph Frattaroli |
3/4/5
|
Cheif Financial Officer |
—
mixed-class rows
|
138,091
mixed-class rows
|
$38,473 | — | 01 Mar 2023 | |
| Elizabeth G. O'Farrell |
3/4/5
|
Director |
—
class O/S missing
|
40,000
|
— | — | 24 Jun 2022 |
Institutional Holders of Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (IKT) as of Q4 2023
As of 31 Dec 2023,
Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (IKT) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
235,004 shares.
The largest 10 holders included
VANGUARD GROUP INC, BLAIR WILLIAM & CO/IL, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Redmond Asset Management, LLC, STATE STREET CORP, Tower Research Capital LLC (TRC), ROYAL BANK OF CANADA, MORGAN STANLEY, and WELLS FARGO & COMPANY/MN.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
13
Q4 2023 holders
11
Holder diff
-2
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.